Rolf Ehrnstrom, Chairman
Rolf Ehrnstrom has more than 30 years of scientific, technical and commercial experience from small, medium and large sized life science and diagnostics companies on the international arena. For the last 20 years he held senior executive management roles. Rolf has extensive experience in product, technology and strategic development in the life science and diagnostics industry. He has a track record of leading large operational organizations (>200 staff), restructuring of large R&D organizations, integration of acquired companies as well as managing rapid growth in new startups. Much of his experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. His responsibilities have ranged from all technical disciplines within R&D as well as IP, Regulatory & Medical & Clinical Affairs, Scientific Relations/Profiling and External Scientific Collaborations. In recent years a special focus has been in the fields of Personalized Medicine, companion diagnostics and technology innovation. Rolf holds a MSc in biochemistry & biotechnology engineering from Royal Institute of Technology, Stockholm Sweden.
Mikael Orum, Board Member
Mikael is Founder and Partner of Ventac Partners and has 40 years of executive experience in finance and biotech. He is currently CEO and Chairman (and co-founder) of Avexxin AS, Co-founder and Board Member of Idogen AB, which listed on Swedish Aktietorget in 2015, and Chairman of RhoVac AB, which listed on Swedish Aktietorget in 2016. He has raised $100Mio in risk capital for biotech and pharma ventures. He has been responsible for multiple licensing deals in USA, Europe, Japan and China. He was co-founder and CEO of Exiqon, which was listed on Nasdaz OMX in 2007 from 1995-2002. He was co-founder of Santaris Pharma which sold to Hoffman la-Roche in 2014 for $450 Mio. Mikael has business and legal educations from Copenhagen Business College, Danish Bankers Academy, Copenhagen Business School and Copenhagen University.
Mikael B. Waitzkin, Board Member
Michael B. Waitzkin is the Deputy Director of the Duke Initiative for Science & Society and teaches courses in the graduate, law and medical schools on issues of science law, policy and ethics. Before coming to Duke, he practiced law in the District of Columbia for 35 years and has extensive experience in advising the biomedical research community on issues relating to legal and regulatory strategy and ethics. He served as Special Counsel to the President in the White House Counsel’s Office. He attended the University of Virginia (BA 1971; Phi Beta Kappa, Echols Scholar), Stanford Law School (JD 1974) and Yale Law School (LLM 1975, Commonwealth Fellow in Law, Science and Medicine).